Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial
Pietro Di Santo(University of Ottawa), Brennan Mao(University of Ottawa), Jordan Bernick(St. Michael's Hospital), Caroline McGuinty(University of Ottawa), Jeffrey A. Marbach(Tufts Medical Center), Steven Hawken(Population Health Research Institute), Juan Russo(University of Ottawa), Gianni D’Egidio(University of Ottawa), Richard G. Jung(University of Ottawa), Rebecca Mathew(University of Ottawa), Christopher Glover(University of Ottawa), Omar Abdel‐Razek(University of Ottawa), Pouya Motazedian(University of Ottawa), Trevor Simard(University of Ottawa), Derek So(University of Ottawa), F. Daniel Ramirez(University of Ottawa), Benjamin Hibbert(University of Ottawa), Kevin E. Boczar(University of Ottawa), Alexander Dick(University of Ottawa), George A. Wells(University of Ottawa), Simon Parlow(University of Ottawa), Stephanie Skanes(University of Ottawa)
Cited by 54
Related Papers
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
|The Lancet|2005|2.9k
Sex Differences in Thoracic Aortic Aneurysm Growth
|Hypertension|2018|117
Safety and Efficacy of Femoral Access vs Radial Access in ST-Segment Elevation Myocardial Infarction
|JAMA Cardiology|2020|114
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention
|JACC: Cardiovascular Interventions|2024|93